XRP (XRP) is 1511.3× the size of Bio Protocol (BIO) by market capitalisation. Over the past 1 year, XRP is ahead by 31.3 percentage points (BIO -84.1% against XRP -52.8%). Their daily returns move loosely together (correlation 0.45 across 399 shared trading days). BIO has been the more volatile of the two, at 151% annualised against XRP's 66%.
| Period | BIO | XRP | Ahead |
|---|---|---|---|
| 7 days | +9.89% | +3.23% | BIO |
| 30 days | -10.29% | +11.22% | XRP |
| 90 days | -9.94% | +25.39% | XRP |
| 1 year | -84.08% | -52.83% | XRP |
| Metric | BIO | XRP |
|---|---|---|
| Max drawdown (400d) | -93.6% | -68.2% |
| Risk-adjusted return (90d) | -0.13 | 0.38 |
| Best 30 days (past year) | +253.8% | +41.9% |
| Worst 30 days (past year) | -52.7% | -47.3% |
Relative strength over 90 days: XRP outperformed BIO by 28.2% — measured on the BIO/XRP ratio, so it holds regardless of market direction.
Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.